Guidelines for Burr Hole Surgery in Combination With Tumor Treating Fields for Glioblastoma: A Computational Study on Dose Optimization and Array Layout Planning

Tumor treating fields (TTFields) is an anti-cancer technology increasingly used for the treatment of glioblastoma. Recently, cranial burr holes have been used experimentally to enhance the intensity (dose) of TTFields in the underlying tumor region. In the present study, we used computational finite element methods to systematically characterize the impact of the burr hole position and the TTFields transducer array layout on the TTFields distribution calculated in a realistic human head model. We investigated a multitude of burr hole positions and layouts to illustrate the basic principles of optimal treatment planning. The goal of the paper was to provide simple rules of thumb for physicians to use when planning the TTFields in combination with skull remodeling surgery. Our study suggests a number of key findings, namely that (1) burr holes should be placed directly above the region of interest, (2) field enhancement occurs mainly underneath the holes, (3) the ipsilateral array should directly overlap the holes and the contralateral array should be placed directly opposite, (4) arrays in a pair should be placed at far distance and not close to each other to avoid current shunting, and finally (5) rotation arrays around their central normal axis can be done without diminishing the enhancing effect of the burr holes. Minor deviations and adjustments (<3 cm) of arrays reduces the enhancement to some extent although the procedure is still effective in these settings. In conclusion, our study provides simple guiding principles for implementation of dose-enhanced TTFields in combination with burr-holes. Future studies are required to validate our findings in additional models at the patient specific level.

[1]  E. Wong,et al.  Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial , 2021, BMC Cancer.

[2]  P. Wen,et al.  Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  A. Korshoej,et al.  Improving Tumor-Treating Fields with Skull Remodeling Surgery, Surgery Planning, and Treatment Evaluation with Finite Element Methods , 2020, Brain and Human Body Modeling 2020.

[4]  Koenraad Van Leemput,et al.  Accurate and robust whole-head segmentation from magnetic resonance images for individualized head modeling , 2020, NeuroImage.

[5]  Oury Monchi,et al.  Impact of Peritumoral Edema During Tumor Treatment Field Therapy: A Computational Modelling Study , 2020, IEEE Transactions on Biomedical Engineering.

[6]  E. Wong,et al.  Finite element analysis of Tumor Treating Fields in a patient with posterior fossa glioblastoma , 2020, Journal of Neuro-Oncology.

[7]  A. Korshoej,et al.  OptimalTTF-1: Enhancing tumor treating fields therapy with skull remodeling surgery. A clinical phase I trial in adult recurrent glioblastoma , 2020, Neuro-oncology advances.

[8]  A. Korshoej,et al.  University of Southern Denmark Estimation of TTFields Intensity and Anisotropy with Singular Value Decomposition: A New and Comprehensive Method for Dosimetry of TTFields , 2019 .

[9]  S. Toms,et al.  Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial. , 2019, International journal of radiation oncology, biology, physics.

[10]  Kristoffer Hougaard Madsen,et al.  A principled approach to conductivity uncertainty analysis in electric field calculations , 2019, NeuroImage.

[11]  A. Thielscher,et al.  Optimization of tumor treating fields using singular value decomposition and minimization of field anisotropy , 2019, Physics in medicine and biology.

[12]  S. Toms,et al.  Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial , 2018, Journal of Neuro-Oncology.

[13]  Axel Thielscher,et al.  Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations , 2018, PloS one.

[14]  Axel Thielscher,et al.  Estimating the Intensity and Anisotropy of Tumor Treating Fields Jsing Singular Value Decomposition. Towards a More Comprehensive Estimation of Anti-tumor Efficacy , 2018, 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[15]  A. Thielscher,et al.  A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling , 2018, IEEE Reviews in Biomedical Engineering.

[16]  Eric T. Wong,et al.  End-to-end workflow for finite element analysis of tumor treating fields in glioblastomas , 2017, Physics in medicine and biology.

[17]  A. Thielscher,et al.  Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study , 2017, PloS one.

[18]  Edwin Lok,et al.  Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma , 2017, Cancer medicine.

[19]  A. Thielscher,et al.  Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study , 2016, PloS one.

[20]  Axel Thielscher,et al.  Field modeling for transcranial magnetic stimulation: A useful tool to understand the physiological effects of TMS? , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[21]  Ricardo Salvador,et al.  The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study , 2015, Physics in medicine and biology.

[22]  Alexander Opitz,et al.  Determinants of the electric field during transcranial direct current stimulation , 2015, NeuroImage.

[23]  P. Basser,et al.  Predicting the electric field distribution in the brain for the treatment of glioblastoma , 2014, Physics in medicine and biology.

[24]  R. Vernhout,et al.  Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. , 2014, The Lancet. Oncology.

[25]  Markus Zahn,et al.  Three-dimensional head model Simulation of transcranial magnetic stimulation , 2004, IEEE Transactions on Biomedical Engineering.

[26]  E. Dekel,et al.  Disruption of cancer cell replication by alternating electric fields. , 2004, Cancer research.

[27]  Ralph Morrison,et al.  The Electric Field , 2003 .

[28]  E. Wong,et al.  Insights from Computer Modeling: Analysis of Physical Characteristics of Glioblastoma in Patients Treated with Tumor-Treating Fields , 2019, Brain and Human Body Modeling.

[29]  Ricardo Salvador,et al.  Modeling Tumor Treating fields (TTFields) application within a realistic human head model , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).